
Changhwa J. Cheu
Examiner (ID: 6970)
| Most Active Art Unit | 1678 |
| Art Unit(s) | 1678, 1677, 1641 |
| Total Applications | 1728 |
| Issued Applications | 1108 |
| Pending Applications | 178 |
| Abandoned Applications | 490 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12866362
[patent_doc_number] => 20180180629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => ACTIVATORS OF TonEBP FOR USE FOR HYDRATING SKIN
[patent_app_type] => utility
[patent_app_number] => 15/831769
[patent_app_country] => US
[patent_app_date] => 2017-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15831769
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/831769 | Activators of TonEBP for use for hydrating skin | Dec 4, 2017 | Issued |
Array
(
[id] => 15212873
[patent_doc_number] => 20190369123
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/485102
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5457
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485102
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485102 | ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF | Nov 14, 2017 | Abandoned |
Array
(
[id] => 15180855
[patent_doc_number] => 20190361019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-28
[patent_title] => ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/485098
[patent_app_country] => US
[patent_app_date] => 2017-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5374
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485098 | ACPA-NEGATIVE RA DIAGNOSTIC MARKER AND APPLICATION THEREOF | Nov 14, 2017 | Abandoned |
Array
(
[id] => 13053761
[patent_doc_number] => 10048266
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-14
[patent_title] => Diagnostic biomarkers and therapeutic targets for pancreatic cancer
[patent_app_type] => utility
[patent_app_number] => 15/809555
[patent_app_country] => US
[patent_app_date] => 2017-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 7466
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15809555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/809555 | Diagnostic biomarkers and therapeutic targets for pancreatic cancer | Nov 9, 2017 | Issued |
Array
(
[id] => 12234274
[patent_doc_number] => 20180067138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients'
[patent_app_type] => utility
[patent_app_number] => 15/803252
[patent_app_country] => US
[patent_app_date] => 2017-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 41235
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15803252
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/803252 | Lipidomic biomarkers for identification of high-risk coronary artery disease patients | Nov 2, 2017 | Issued |
Array
(
[id] => 14932929
[patent_doc_number] => 20190302102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER, AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/346212
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -51
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346212
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346212 | COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER, AND METHODS FOR USING THE SAME | Oct 25, 2017 | Abandoned |
Array
(
[id] => 14854909
[patent_doc_number] => 10416174
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2019-09-17
[patent_title] => Diagnosis and prognosis for chronic fatigue syndrome
[patent_app_type] => utility
[patent_app_number] => 15/795134
[patent_app_country] => US
[patent_app_date] => 2017-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11977
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15795134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/795134 | Diagnosis and prognosis for chronic fatigue syndrome | Oct 25, 2017 | Issued |
Array
(
[id] => 18188565
[patent_doc_number] => 11579141
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound
[patent_app_type] => utility
[patent_app_number] => 16/344356
[patent_app_country] => US
[patent_app_date] => 2017-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 45
[patent_no_of_words] => 40900
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 933
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16344356
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/344356 | Methods for identifying a non-healing skin wound and for monitoring the healing of a skin wound | Oct 22, 2017 | Issued |
Array
(
[id] => 12157773
[patent_doc_number] => 20180029034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'METHODS FOR CONDUCTING MULTIPLEXED ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 15/784399
[patent_app_country] => US
[patent_app_date] => 2017-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 37359
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15784399
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/784399 | Methods for conducting multiplexed assays | Oct 15, 2017 | Issued |
Array
(
[id] => 12261735
[patent_doc_number] => 20180080931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'REGULATORY BRAIN SPECIFIC CTYOPLASMIC RNAS (BC RNAs) AND METHODS OF USE THEREOF IN DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC LUPUS'
[patent_app_type] => utility
[patent_app_number] => 15/729034
[patent_app_country] => US
[patent_app_date] => 2017-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7850
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729034
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729034 | Regulatory brain specific ctyoplasmic RNAs (BC RNAs) and methods of use thereof in diagnosis and treatment of neuropsychiatric lupus | Oct 9, 2017 | Issued |
Array
(
[id] => 15457349
[patent_doc_number] => 20200041499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => MULTI-PROTEASE METHOD
[patent_app_type] => utility
[patent_app_number] => 16/339810
[patent_app_country] => US
[patent_app_date] => 2017-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339810 | Multi-protease method | Oct 5, 2017 | Issued |
Array
(
[id] => 15150339
[patent_doc_number] => 20190353647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => NOVEL REAL-TIME MULTIPLEXED, MULTI-COLOR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER ASSAY, APPARATUS, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/339199
[patent_app_country] => US
[patent_app_date] => 2017-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16339199
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/339199 | NOVEL REAL-TIME MULTIPLEXED, MULTI-COLOR BIOLUMINESCENCE RESONANCE ENERGY TRANSFER ASSAY, APPARATUS, AND USES THEREOF | Oct 2, 2017 | Abandoned |
Array
(
[id] => 12685321
[patent_doc_number] => 20180120273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => IONIC STRENGTH-MEDIATED PH GRADIENT ION EXCHANGE CHROMATOGRAPHY
[patent_app_type] => utility
[patent_app_number] => 15/721389
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36380
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15721389
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/721389 | Ionic strength-mediated pH gradient ion exchange chromatography | Sep 28, 2017 | Issued |
Array
(
[id] => 14569467
[patent_doc_number] => 20190212340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES
[patent_app_type] => utility
[patent_app_number] => 16/336074
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16113
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16336074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/336074 | AN ELISA-LIKE ASSAY FOR QUANTIFYING ENZYMATIC ACTIVITIES OF MONO-ADP-RIBOSYLTRANSFERASES | Sep 26, 2017 | Abandoned |
Array
(
[id] => 18154089
[patent_doc_number] => 11567064
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Method of predicting the likelihood of success of gene therapy
[patent_app_type] => utility
[patent_app_number] => 16/330362
[patent_app_country] => US
[patent_app_date] => 2017-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5140
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16330362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/330362 | Method of predicting the likelihood of success of gene therapy | Sep 26, 2017 | Issued |
Array
(
[id] => 15365997
[patent_doc_number] => 20200018763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => METHODS TO ASSESS BINDING AGENT SPECIFICITY
[patent_app_type] => utility
[patent_app_number] => 16/335774
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335774
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/335774 | METHODS TO ASSESS BINDING AGENT SPECIFICITY | Sep 25, 2017 | Abandoned |
Array
(
[id] => 17098172
[patent_doc_number] => 20210285963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage
[patent_app_type] => utility
[patent_app_number] => 16/338729
[patent_app_country] => US
[patent_app_date] => 2017-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16338729
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/338729 | Inspection Method Enabling Specific Diagnosis of Pathological State of Diabetic Nephropathy at Early Stage | Sep 25, 2017 | Abandoned |
Array
(
[id] => 17621189
[patent_doc_number] => 11340237
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-24
[patent_title] => Metabolite biomarkers for diseases associated with the contact activation system
[patent_app_type] => utility
[patent_app_number] => 16/333101
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 15778
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333101 | Metabolite biomarkers for diseases associated with the contact activation system | Sep 14, 2017 | Issued |
Array
(
[id] => 14749327
[patent_doc_number] => 20190257837
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => Nidogen-1 Fragments Assay
[patent_app_type] => utility
[patent_app_number] => 16/333444
[patent_app_country] => US
[patent_app_date] => 2017-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333444 | Nidogen-1 Fragments Assay | Sep 12, 2017 | Abandoned |
Array
(
[id] => 16957174
[patent_doc_number] => 11061027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-13
[patent_title] => Materials and methods for evaluating and treating cancer
[patent_app_type] => utility
[patent_app_number] => 16/334978
[patent_app_country] => US
[patent_app_date] => 2017-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 13
[patent_no_of_words] => 7921
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16334978
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/334978 | Materials and methods for evaluating and treating cancer | Sep 11, 2017 | Issued |